[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medtronic Inc (MDT)

Medtronic Inc (MDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 97,767,848
  • Shares Outstanding, K 1,283,885
  • Annual Sales, $ 33,537 M
  • Annual Income, $ 4,662 M
  • EBIT $ 7,957 M
  • EBITDA $ 10,818 M
  • 60-Month Beta 0.62
  • Price/Sales 2.76
  • Price/Cash Flow 10.06
  • Price/Book 2.03

Options Overview Details

View History
  • Implied Volatility 28.48% (+0.33%)
  • Historical Volatility 21.89%
  • IV Percentile 98%
  • IV Rank 92.34%
  • IV High 29.67% on 02/13/26
  • IV Low 14.14% on 12/09/25
  • Expected Move (DTE 5) 1.64 (2.15%)
  • Put/Call Vol Ratio 0.60
  • Today's Volume 11,959
  • Volume Avg (30-Day) 9,228
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 154,400
  • Open Int (30-Day) 135,305
  • Expected Range 74.51 to 77.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/26
See More
  • Average Estimate $1.58
  • Number of Estimates 10
  • High Estimate $1.69
  • Low Estimate $1.53
  • Prior Year $1.62
  • Growth Rate Est. (year over year) -2.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
75.91 +0.32%
on 05/08/26
88.67 -14.12%
on 04/14/26
-12.50 (-14.10%)
since 04/08/26
3-Month
75.91 +0.32%
on 05/08/26
103.63 -26.51%
on 02/09/26
-26.75 (-26.00%)
since 02/06/26
52-Week
75.91 +0.32%
on 05/08/26
106.33 -28.38%
on 11/26/25
-7.47 (-8.93%)
since 05/08/25

Most Recent Stories

More News
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement

$15 million payment fulfills previously scheduled tranche under royalty-based financing agreement, bringing total capital received from Ligand to $40 million to date in exchange for tiered royalty interest...

LGND : 221.41 (+5.27%)
MDT : 76.15 (-2.32%)
OBIO : 4.04 (+2.80%)
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement

Payment fulfills previously disclosed funding commitment of $20 million and supports planned completion of the BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) evaluating Atrioventricular Interval...

MDT : 76.15 (-2.32%)
OBIO : 4.04 (+2.80%)
Medtronic Stock Outlook: Is Wall Street Bullish or Bearish?

Although Medtronic has lagged behind the S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

XLV : 143.49 (-0.85%)
$SPX : 7,398.93 (+0.84%)
MDT : 76.15 (-2.32%)
3 Reasons Analysts Love DexCom

Continuous glucose monitoring devices are vital to those with type 2 diabetes, and DexCom is cementing its position as a leader in this growing market.

MDT : 76.15 (-2.32%)
DXCM : 60.61 (-0.49%)
FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy

Atrioventricular Interval Modulation (“AVIM”) Therapy Food and Drug Administration (“FDA”) Breakthrough Device Designations span the broader population of patients with uncontrolled hypertension...

MDT : 76.15 (-2.32%)
OBIO : 4.04 (+2.80%)
Medtronic announces CE Mark for Stealth AXiS™ surgical system

Following recent FDA clearances, Medtronic is accelerating access to integrated planning, navigation, and robotics platform across Europe

MDT : 76.15 (-2.32%)
Medtronic announces key Affera™ clinical study milestones for Sphere-9™ and Sphere-360™ catheters as global adoption continues

GALWAY, Ireland and CHICAGO , April 25, 2026 /PRNewswire/ -- Medtronic plc, (NYSE: MDT), a global leader in healthcare technology, today announced continued momentum for the Affera™ family of technologies...

MDT : 76.15 (-2.32%)
What You Need to Know Ahead of Medtronic's Earnings Release

Medtronic is expected to release its fiscal fourth-quarter earnings soon, and analysts project a single-digit profit drop.

XLV : 143.49 (-0.85%)
$SPX : 7,398.93 (+0.84%)
MDT : 76.15 (-2.32%)
Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026

Pre-randomization Atrioventricular Interval Modulation Therapy (“AVIM Therapy”)  set-up data from the MODERATO II randomized, prospective, multi-center, double-blind, controlled trial show an ...

MDT : 76.15 (-2.32%)
OBIO : 4.04 (+2.80%)
Intuitive Surgical's Selloff Sets Up a 30% Rebound Opportunity

Intuitive Surgical is the leading robotic surgery stock, outpacing consensus estimates and cementing its first-mover status.

MDT : 76.15 (-2.32%)
ISRG : 450.06 (-0.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength is below 30%. The market is in oversold territory. Watch for a potential trend reversal.

See More Share

Business Summary

Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience...

See More

Key Turning Points

3rd Resistance Point 80.12
2nd Resistance Point 79.23
1st Resistance Point 77.69
Last Price 76.15
1st Support Level 75.26
2nd Support Level 74.37
3rd Support Level 72.83

See More

52-Week High 106.33
Fibonacci 61.8% 94.71
Fibonacci 50% 91.12
Fibonacci 38.2% 87.53
Last Price 76.15
52-Week Low 75.91

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.